|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
55,570,000 |
Market
Cap: |
359.54(M) |
Last
Volume: |
17,307 |
Avg
Vol: |
8,066 |
52
Week Range: |
$6.47 - $6.47 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sinovac Biotech is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Co.'s products include: Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a vaccine against influenza; Panflu, a vaccine against the H5N1 influenza virus; Split Viron Pandemic Influenza Vaccine, an influenza vaccine; Panflu.1, a vaccine against the influenza A H1N1 virus; Mumps Vaccine; Inlive, a treatment for HFMD; and Varicella Vaccine, a vaccine for disease caused by the varicella-zoster virus.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ifg Investments Services Inc |
10% Owner |
|
2003-11-04 |
4 |
S |
$0.03 |
$180,836 |
D/D |
(6,027,870) |
0 |
|
- |
|
Wang Lily |
Chief Financial OfficerOfficer |
|
2003-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000,000 |
|
- |
|
Weidong Yin |
President and CEOOfficer |
|
2003-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,544,830 |
|
- |
|
Ifg Investments Services Inc |
10% Owner |
|
2003-09-24 |
4 |
S |
$0.03 |
$180,836 |
D/D |
(6,027,870) |
0 |
|
- |
|
Bowering Terry G |
officerTitle |
|
2003-09-24 |
4 |
S |
$0.03 |
$211,345 |
I/I |
(7,044,830) |
0 |
|
- |
|
5 Records found
|
1
|
Page 1 of 1 |
|
|